- Approval Id
- 292e68c14936d641
- Drug Name
- ROYCE RIFAMPICIN CAPSULE 150MG
- Product Name
- ROYCE RIFAMPICIN CAPSULE 150MG
- Approval Number
- SIN16652P
- Approval Date
- 2022-12-07
- Registrant
- GOLDPLUS UNIVERSAL PTE LTD
- Licence Holder
- GOLDPLUS UNIVERSAL PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- CAPSULE
- Dosage
- **Dosage and Administration :**
Royce Rifampicin should be given as a single dose before meals to ensure rapid and complete absorption. Dosage should be adjusted according to body weight of patients.
**Adults :** 450 – 600mg daily as a single dose (based on approximately 10mg per kg body weight). Those patients 50 kg and over should take 600mg daily, whilst patients under 50 kg should take 450mg.
**Children:** Up to 20mg per kg body weight daily to a maximum of 600mg as a single dose.
**Premature and newborn infants :** 10mg/kg once daily.
Royce Rifampicin should be given with other effective antituberculosis drugs to prevent the possible emergence of rifampicin-resistant strains of mycobacteria.
- Route Of Administration
- ORAL
- Indication Info
- **Indication :**
Royce Rifampicin Capsule used in combination with other active antituberculosis drugs is indicated in the treatment of all forms of tuberculosis. It is also effective against many atypical strains of mycobacteria.
- Contraindications
- **Contraindication :**
Jaundice; hypersensitivity to Rifampicin antibiotics; first trimester of pregnancy; premature and newborn infants; are concurrently receiving saquinavir/ritonavir therapy.
- Atc Code
- J04AB02
- Atc Item Name
- rifampicin
- Pharma Manufacturer Name
- GOLDPLUS UNIVERSAL PTE LTD
- Company Detail Path
- /organization/7cb5b69d6eb36564/goldplus-universal-pte-ltd
